EVALUATE THE EFFICACY OF LONG-COURSE NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE II–III LOW RECTAL CANCER TREATED AT 108 MILITARY CENTRAL HOSPITAL. YHCĐ 2026, 67 (CĐ7-Trường ĐH Y Dược Hải Phòng). https://doi.org/10.52163/yhc.v67iCD7.5614.